DiaCarta partners with OncoAssure for prostate cancer test commercialization
DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company headquartered at NovaUCD in Dublin.
Source: news-medical.net